Arvinas competitors and similar companiesClear all
Arvinas's competitors and similar companies include Foghorn Therapeutics, Lyell, Elicio Therapeutics and OnQuality Pharmaceuticals.
 Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. |  Elicio Therapeutics Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers. |  OnQuality Pharmaceuticals OnQuality Pharmaceuticals is a pharmaceutical company specialized in the development and commercialization of drugs and drug delivery systems in the area of oncology. | ||
Founding Date | Founding Date N/A | Founding Date 2016 | Founding Date 2018 | Founding Date 2011 | Founding Date 2019 |
Type | Type Public | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations New Haven, US HQ | Locations Cambridge, US HQ Cambridge, US | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations Cambridge, US HQ | Locations HQ |
Employees | Employees 13329% increase | Employees 85 | Employees 188 | Employees 22 | Employees 147% decrease |
Valuation ($) | Valuation ($) 1.4 b | Valuation ($) 198.1 m | Valuation ($) 501.1 m | Valuation ($) N/A | Valuation ($) N/A |
Twitter followers | Twitter followers 3 k | Twitter followers 1 k | Twitter followers N/A | Twitter followers N/A | Twitter followers 108 |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 16 | Number of tweets (last 30 days) 12 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 3.6 | Average likes per tweet (last 30 days) 1.8 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 87.5% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A |
Employee Rating | Employee Rating 4.7 | Employee Rating 4.2 | Employee Rating 3.4 | Employee Rating 5 | Employee Rating N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $131.4m (FY, 2022) | Revenue (est.) $19.2m (FY, 2022) | Revenue (est.) $84.7m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($282.5m) (FY, 2022) | Net income ($112.9m) (FY, 2022) | Net income ($183.1m) (FY, 2022) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 111.6m | Total funding raised $ 50m | Total funding raised N/A | Total funding raised $ 150.3m | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Foghorn Therapeutics
HQ
Cambridge, US
Employees
85
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company
Lyell
HQ
South San Francisco, US
Employees
188
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
View companyElicio Therapeutics
HQ
Cambridge, US
Employees
22
Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers.
View companyOnQuality Pharmaceuticals
HQ
Employees
14↓ 7% decrease
OnQuality Pharmaceuticals is a pharmaceutical company specialized in the development and commercialization of drugs and drug delivery systems in the area of oncology.
View company